| Hb < 110 g/l during pregnancy N = 301 | Hb ≥ 110 g/l during pregnancy N = 972 | B/ORa | CI 95% | p-value |
---|---|---|---|---|---|
Antenatal depressive symptoms | |||||
 EPDS  Early pregnancy | 5.0 (0–26) | 5.0 (0–27) | 0.24 | -0.37–0.85 | 0.446 |
 EPDS  Mid-pregnancy | 4.0 (0–22) | 4.0 (0–25) | -0.11 | -0.73–0.52 | 0.740 |
 EPDS  Late pregnancy | 4.0 (0–19) | 4.0 (0–19) | 0.15 | -0.49–0.79 | 0.642 |
 EPDS ≥ 10  Late pregnancy | 28/189 (14.8%) | 95 (13.6%) | OR 0.96 | 0.59–1.57 | 0.882 |
Postpartum depressive symptoms | |||||
 EPDS  3 months postpartum | 4.0 (0–17) | 3.0 (0–21) | 0.30 | -0.38–0.98 | 0.381 |
 EPDS  6 months postpartum | 3.0 (0–24) | 3.0 (0–22) | 0.11 | -0.72–0.94 | 0.795 |
 EPDS ≥ 10  3 months postpartum | 16/167 (9.6%) | 60 (9.9%) | OR 1.01 | 0.54–1.85 | 0.988 |
 EPDS ≥ 10  6 months postpartum | 20/139 (14.4%) | 55 (10.7%) | OR 1.32 | 0.75–2.31 | 0.334 |
Antenatal general and pregnancy-related anxiety symptoms | |||||
 SCL  Early pregnancy | 3.0 (0–30) | 2.0 (0–28) | 0.62 | 0.02–1.23 | 0.043* |
 SCL  Mid-pregnancy | 3.0 (0–21) | 3.0 (0–29) | 0.19 | -0.47–0.85 | 0.575 |
 SCL  Late pregnancy | 2.0 (0–25) | 2.0 (0–27) | 0.10 | -0.55–0.76 | 0.756 |
 PRAQ  Early pregnancy | 21.0 (12–40) | 22.0 (11–45) | -0.10 | -2.45–2.25 | 0.933 |
 PRAQ  Mid-pregnancy | 22.0 (10–43) | 23.0 (10–46) | -1.17 | -2.22– (-0.12) | 0.029* |
 PRAQ  Late pregnancy | 24.0 (10–50) | 23.0 (10–49) | -0.35 | -1.45–0.75 | 0.535 |
Postnatal anxiety symptoms | |||||
 SCL  3 months postpartum | 1.0 (0–17) | 1.0 (0–24) | 0.23 | -0.40–0.86 | 0.469 |
 SCL  6 months postpartum | 1.0 (0–20) | 1.0 (0–29) | 0.16 | -0.63–0.94 | 0.693 |